Cme Group Inc. · NASDAQ:CME
Cme — Q1 2020 Earnings Presentation
6 slides from Cme's earnings presentation, Apr 29, 2020
Slide 1: 1Q 2020 Summary
1Q 2020 Earnings Commentary Revenue Adjusted Diluted EPS 1Q 2020 Summary Adjusted Expense* • CME Group’s global investments in products, processes, technology and in millions employees, providing electronic markets as well as margin, capital and total cost $1,750 $2.50 efficiencies, positioned the c
Slide 2: 1Q 2020 Highlights
1Q 2020 Earnings Commentary - Unaudited 1Q 2020 Highlights The execution of CME Group’s focused strategy positioned the company well to help market participants manage risk during such unique circumstances. Our quarterly results reflect how our clients across the world turned to our markets to manag
Slide 3: Non-U.S. ADV and options ADV highlights
1Q 2020 Earnings Commentary - Unaudited 1Q20 non-U.S. ADV grew 56% to a record 7.3 million contracts, with record ADV across EMEA and APAC • 1Q20 non-U.S. ADV highlights: 4.0 Non-U.S. ADV by Product Line • Interest Rate ADV up 45% to 3.6 million contracts 3.0 • Equity Index ADV up 151% to 1.7 millio
Slide 4: 1Q 2020 Product Detail - Financials and Commodities
1Q 2020 Earnings Commentary - Unaudited Significant 1Q20 OTC activity • Notional ADV across all products and currencies of $89 billion, up 21% from 4Q19 • Record revenue of $20.8 million • Record $7 billion in initial margin savings through portfolio margining of Interest Rate swaps and futures 1Q 2
Slide 5: Financial Results
1Q 2020 Earnings Commentary - Unaudited Financial Results Dividends Paid* $ in millions $2,500 • 1Q20 revenue was $1.52 billion, including $189 million Regular Quarterly generated by legacy NEX businesses Dividend • 1Q20 clearing and transaction fees revenue totaled $1.3 billion, including approxima
Slide 6: Use of Non-GAAP Measures; Forward-Looking Statements
1Q 2020 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation mate